
|Articles|June 1, 2021
The many facets of stone disease: a practical outlook on 24-hour urine and genetic testing
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix
5











